Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
November-2017 Volume 14 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2017 Volume 14 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Identification of key genes influenced by fixation stability in early fracture hematoma and elucidation of their roles in fracture healing

  • Authors:
    • Chengxue Wang
    • Baochang Qi
    • Congfeng Zhang
    • Jieping Cheng
  • View Affiliations / Copyright

    Affiliations: Department of Orthopedic Trauma, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China, Department of Orthopedics, The Second People's Hospital of Yushu, Changchun, Jilin 130041, P.R. China, Department of Orthopedics, The Second Hospital of Jilin University, Changchun, Jilin 130041, P.R. China
    Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 4633-4638
    |
    Published online on: September 22, 2017
       https://doi.org/10.3892/etm.2017.5192
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The present study aimed to identify the key genes influenced by fixation stability in early fracture hematoma and to elucidate their roles in fracture healing. The GSE53256 gene expression profile, including six fracture hematoma tissues, was downloaded from the Gene Expression Omnibus database. The differentially expressed genes (DEGs) in the fracture hematoma tissues from old rats with rigid fixation compared with semi‑rigid fixation were identified using the limma package. Furthermore, Gene Ontology (GO) enrichment analysis for DEGs was performed using BiNGO, and a protein‑protein interaction (PPI) network was constructed based on the Search Tool for the Retrieval of Interacting Genes database. A total of 265 DEGs (158 upregulated and 107 downregulated) in the fracture hematoma tissues were screened out. Additionally, the overrepresented GO terms were mainly associated with the extracellular region, positive regulation of locomotion and response to external stimulus. Transforming growth factor, β 1 (Tgfβ1), chemokine (C‑X‑C motif) ligand 12 (Cxcl12), matrix metallopeptidase 9 (mmp9) and serpin peptidase inhibitor, clade E, member 1 (serpine1) had higher degrees and were hub nodes in the PPI network. In conclusion, fixation stability may influence the fracture healing process, and important DEGs, including Cxcl12, mmp9, Tgfβ1 and serpine1, may be important in this process.

Introduction

Bone regeneration is a cascade of complex biological events of bone induction and translation, and is required to optimize skeletal repair and restore skeletal function (1,2). It has been shown to be involved in numerous conditions, including skeletal reconstruction of large bone defects created by trauma, orthopedic surgery and osteotomy (3). The most common form of bone regeneration is fracture healing in the clinical setting (4). Thus, understanding the mechanism of fracture healing and accelerating the overall regeneration process will help to improve the healing outcome and alleviate the pain felt be patients to some extent.

Fracture consolidation can be influenced by mechanical factors, and mechanical stability is confirmed to be a key factor for determining the healing outcome of bone regeneration (5,6). It has also been demonstrated that the optimal fixation rigidity, which is neither too stiff nor too gentle, is associated with the fastest growth of the bone (7). Ranganathan et al (8) also reported that an appropriate fixation stability was necessary to promote timely fracture healing. In addition, the early fracture hematoma has been shown to have potency and potential in fracture healing and has become a subject of attention (9). An in vitro study has indicated that fracture hematoma contains multilineage mesenchymal progenitor cells able to differentiate into a chondrogenic or osteogenic cell type and thus is important in bone healing (10). Furthermore, fracture hematoma has been shown to contain growth factor vascular endothelial growth factor, which is crucial in angiogenesis and fracture healing (11,12). Sarahrudi et al (13) demonstrated that fracture hematoma had significantly higher concentrations of transforming growth factor, β 1 (Tgfβ1) than the peripheral serum of patients. Therefore, the early fracture hematoma may be important in the early healing period and may determine the healing outcome. Furthermore, gene expression in the early fracture hematoma is also reported to be influenced by fixation stability (14). However, it so far remains incompletely understood what molecules are involved in the early fracture hematoma associated with fixation stability, as well as their roles during fracture healing.

In a previous study, GSE53256 microarray data was utilized to analyze the interactive effects of age and mechanical stability on bone defect healing using an early transcriptional analysis (14). In the present study, the GSE53256 microarray data was downloaded and a bioinformatics approach was applied in order to identify the differentially expressed genes (DEGs) in fracture hematoma tissues from old rats with rigid fixation in comparison with fracture hematoma tissues from old rats with semi-rigid fixation. In addition, functional enrichment analysis and protein-protein interaction (PPI) network analysis were performed. The aim was to identify the potential key genes influenced by fixation stability in early fracture hematoma, as well as to elucidate their roles in the process of fracture healing.

Materials and methods

Affymetrix microarray data

The gene expression profile of GSE53256 deposited by Ode et al (14) was obtained from the Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) database; the profile was performed on the platform of GPL1335 [Rat 230_2] Affymetrix Rat Genome 230 2.0 Array (Affymetrix, Santa Clara, CA, USA). A total of 12 fracture hematoma tissues from four groups of Sprague-Dawley rats with a 1.5-mm osteotomy gap in the femora with varying age (12 vs. 52 weeks) and fixator stiffness (rigid vs. semi-rigid fixation; n=3 per group) were used for the development of this microarray data. However, in this study, only the expression data from the six fracture hematoma tissues of the old (52-week-old) rats after 3 days of an osteotomy and with rigid or semi-rigid fixation were used for the analysis.

Data preprocessing and DEG screening

The raw expression data were first background corrected and quantile normalized by the robust multiarray average (15) method with application of the Affy package in R/Bioconductor. Next, the DEGs in fracture hematoma tissues from old rats with rigid fixation compared with fracture hematoma tissues from old rats with semi-rigid fixation were identified using limma (16) package in R/Bioconductor (http://www.bioconductor.org/packages/release/bioc/html/limma.html), where a fold-change ≥1.5 and P<0.05 were defined as the cutoff value. Additionally, hierarchical clustering analysis of the DEGs was performed and visualized using the pheatmap package in R (17).

Functional enrichment analysis

Gene Ontology (GO; http://www.geneontology.org) (18) is widely applied for the biological unification of large-scale gene lists, which are mainly classified into three categories, namely biological process (BP), molecular function and cellular component. In the present study, GO-BP enrichment analysis for DEGs was performed using the BiNGO (http://www.psb.ugent.be/cbd/papers/BiNGO/) (19) plugin and was then visualized using Cytoscape software (20). In order to reduce false positives, multiple testing correction was performed using the Beniamini-Hochberg method (21), and the P-value was then adjusted as the false discovery rate (FDR). Finally, significant enrichment threshold of GO-BP terms was set as FDR<0.05.

PPI network construction

The Search Tool for the Retrieval of Interacting Genes (STRING; http://string-db.org/) (22) database collects experimental and predicted information associated with the interactions of protein pairs in a given cell context via calculating the combined score of PPIs. The higher the combined score, the more reliable the PPIs are. In the present study, PPIs with a combined score >0.4 were considered to be significant. Thus, the DEGs were mapped into PPIs and a PPI network was then constructed based on the information of the STRING database.

Results

DEG analysis

Following data processing, the data was normalized for subsequent analysis. A total of 265 DEGs were obtained using the limma package in fracture hematoma tissues from old rats with rigid fixation compared with fracture hematoma tissues from old rats with semi-rigid fixation, and included 158 upregulated and 107 downregulated genes. For example, chemokine (C-X-C motif) ligand 12 (Cxcl12), chemokine (C-C motif) ligand 9 (Ccl9) and matrix metallopeptidase 9 (mmp9) were upregulated, while Tgfβ1, serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 (serpine1) and angiotensin II receptor, type 1a (Agtr1a) were downregulated. The heat map plot of DEGs derived from hierarchical clustering analysis is shown in Fig. 1.

Figure 1.

Heatmap plot of differentially expressed genes across old samples. The labels on the abscissa axis below the plot represent samples, and the markings above the plot represent the clustering of samples. The markings on the longitudinal axis represent the clustering of differentially expressed genes. Red represents high expression and green represents low expression.

GO enrichment analysis

In order to understand the function of these DEGs, GO enrichment analysis was performed for DEGs. Table I displays the top 20 most significant GO-BPs, and the most overrepresented GO terms of these DEGs were found to be associated with the extracellular region, positive regulation of locomotion, response to external stimulus, positive regulation of cell migration and response to wounding.

Table I.

Top 20 most significant pathways.

Table I.

Top 20 most significant pathways.

GO-IDDescriptionCorrected P-value
44421Extracellular region part 2.49×10−12
40017Positive regulation of locomotion 5.06×10−9
9605Response to external stimulus 5.06×10−10
30335Positive regulation of cell migration 1.02×10−9
9611Response to wounding 1.04×10−9
5576Extracellular region 1.53×10−9
51272Positive regulation of cellular component movement 1.80×10−9
42221Response to chemical stimulus 1.85×10−9
32879Regulation of localization 3.69×10−9
5615Extracellular space 6.92×10−9
6954Inflammatory response 1.25×10−8
32502Developmental process 2.14×10−8
30334Regulation of cell migration 2.27×10−8
42330Taxis 2.27×10−8
6935Chemotaxis 2.27×10−8
7275Multicellular organismal development 2.40×10−8
31012Extracellular matrix 3.70×10−8
40011Locomotion 4.00×10−8
48731System development 5.95×10−8
8009Chemokine activity 7.92×10−8
PPI network analysis

Based on the information of the STRING database, the PPI network of DEGs was constructed with 153 nodes and 302 edges (Fig. 2). Additionally, the node degree distribution displayed that this PPI network was a scale-free network (Fig. 3). The biggest characteristic of the scale-free network was that a small number of nodes had higher degrees while the majority of the nodes had lower degrees, indicating that nodes with higher degrees may be important in network connectivity. Therefore, the nodes Tgfβ1 (degree, 20), Cxcl12 (degree, 19), Ccl9 (degree, 18), mmp9 (degree, 17), kinase insert domain receptor (degree, 15), platelet derived growth factor receptor, β polypeptide (degree, 14), serpine1 (degree, 14), cadherin 2 (degree, 13), peroxisome proliferator-activated receptor γ (degree, 13) and Agtr1a (degree, 12) were hub proteins in the PPI network (Table II).

Figure 2.

Protein-protein interaction network of differentially expressed genes. Node size reflects node degree where a larger size reflects a larger degree. Node color reflects fold-change values of the gene; red nodes are upregulated and green nodes are downregulated genes. The grey lines represent the interaction between genes.

Figure 3.

Node degree distribution. The blue line is a fitted power law distribution line. Black data points represent differentially expressed genes.

Table II.

Genes with degree ≥10.

Table II.

Genes with degree ≥10.

GeneNameLog FCDegree
Tgfβ1Transforming growth factor, β 1−1.56766619920
Cxcl12Chemokine (C-X-C motif) ligand 12   0.801690919
Ccl9Chemokine (C-C motif) ligand 9   0.58801202118
Mmp9Matrix metallopeptidase 9   1.75202374217
KdrKinase insert domain receptor   0.84646399215
PdgfrbPlatelet derived growth factor receptor, β polypeptide   0.90642366314
Serpine1Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1−1.1774105914
Cdh2Cadherin 2   0.69178789513
PpargPeroxisome proliferator-activated receptor γ   0.7865807813
Agtr1aAngiotensin II receptor, type 1a−0.733197412
EdnraEndothelin receptor type A   0.63760295411
Ccl20Chemokine (C-C motif) ligand 20   0.80730876510
ItgamIntegrin, α M−1.25217486110
Nt5e5′ nucleotidase, ecto−0.83156823710

[i] FC, fold change.

Discussion

The early phase of bone healing is likely to be sensitive to the conditions of mechanical loading (23). In the present study, a bioinformatics approach was used to identify key genes influenced in fixation stability from fracture hematoma tissues harvested 3 days post-osteotomy. Upregulated genes, including Cxcl12 and mmp9, and downregulated genes, such as Tgfβ1 and serpine1, were identified as hub nodes and appeared to be important in the process of fracture healing associated with fixation stability.

The fracture healing process may be divided into three stages: Acute inflammation, repair and remodeling (24). In the present study, upregulated genes, including Cxcl12 and mmp9, were key inflammatory cytokines and may be involved in the initial inflammatory response as the first step of fracture healing. The chemokine Cxcl12 has been identified to regulate the inflammatory response associated with the healing process (25). Furthermore, it is an important contributor to bone marrow MSC homing and localization within the bone marrow (26). Grassi et al (27) also indicated that Cxcl12 was involved in a number of inflammatory pathologies and was crucial in the regulation of osteoclast differentiation and function. In addition, mmp9 has been confirmed to have effects on skeletal cell differentiation during fracture healing via regulation of the inflammatory response and the inflammatory cell distribution (28). Furthermore, Beamer et al (12) demonstrated that mmp9 was implicated in the regulation of chondrogenic and osteogenic cell differentiation during the early stages of bone repair. Notably, Wang et al (29) indicated that the mechanical environment affected the inflammatory response and influenced skeletal cell differentiation during bone repair via the regulation of mmp9. Therefore, the results of the present study imply that fixation stability may induce an inflammatory response during fracture healing via the regulation of Cxcl12 and mmp9.

Tgfβ1 was identified as a hub node in the PPI network with the highest degree. It is a member of the transforming growth factor-β family and functions as a regulatory protein involved in bone remodeling during the fracture healing process (13). Furthermore, Tgfβ1 is thought to induce the migration of bone mesenchymal stem cells and to regulate the coordination of bone resorption and subsequent bone formation (30). Additionally, it has also been found to be involved in fracture healing through regulation of the activation and differentiation of osteoblasts and osteoclasts (31). Tgfβ1 induces the production of extracellular bone matrix proteins, including alkaline phosphatase, collagen, osteonectin, osteopontin and proteoglycans (32,33), and can regulate different cell types implicated in bone turnover and fracture healing (34). Therefore, Tgfβ1 may be important in the regulation of bone remodeling during the fracture healing process. However, in the present study, Tgfβ1 was downregulated in fracture hematoma tissues from old rats with rigid fixation compared with fracture hematoma tissues from old rats with semi-rigid fixation, implying that rigid fixation may influence bone remodeling during the fracture healing process by the downregulation of Tgfβ1.

Furthermore, serpine1 was identified as another downregulated hub node. Serpine1 [also known as plasminogen activator inhibitor-1 (PAI-1)], as a component of the fibrinolytic system, is the principal inhibitor of plasminogen activators (35). It has been shown to have various functions, including regulation of extracellular matrix (ECM) degradation and cell migration (36). Tamura et al (37) confirmed that PAI-1 suppressed the mRNA expression levels of runt-related transcription factor 2 and type I collagen in primary osteoblasts from mouse calvaria, suggesting that PAI-1 may suppress osteoblast differentiation during the bone repair process. In addition, serpine1 has been reported to be important in the regulation of fracture callus size, cartilage formation and resorption during bone fracture repair (38). Mao et al (24) also demonstrated that PAI-1 may be involved in ECM remodeling and thus be crucial in the bone repair process in patients with diabetes. It may thus be speculated that serpine1 is important in bone fracture repair. In addition, Mao et al (24) also demonstrated that PAI-1 deficiency attenuated diabetic impaired bone repair in patients with diabetes. In the present study, serpine1 was downregulated in fracture hematoma tissues with rigid fixation when compared with those with semi-rigid fixation, indicating that suppression of serpine1 may promote bone repair following treatment using rigid fixation.

In conclusion, the observations of the present study indicate that fixation stability may influence the fracture healing process, and that important DEGs in fracture hematoma, including Cxcl12, mmp9, Tgfβ1 and serpine1 may be important in this process. The present observations shed new light on the molecular mechanism of fracture healing and have implications for future research. However, the small sample size and lack of experimental validation were limitations in the present study. To further validate the results, it would be prudent to perform the same analysis on a group of young rats and compare the two gene sets for common DEGs upon fixation rigidity in young and old rats.

References

1 

Einhorn TA: The cell and molecular biology of fracture healing. Clin Orthop Relat Res. 355 Suppl:S7–S21. 1998. View Article : Google Scholar : PubMed/NCBI

2 

Dimitriou R, Tsiridis E and Giannoudis PV: Current concepts of molecular aspects of bone healing. Injury. 36:1392–1404. 2005. View Article : Google Scholar : PubMed/NCBI

3 

Dimitriou R, Jones E, McGonagle D and Giannoudis PV: Bone regeneration: Current concepts and future directions. BMC Med. 9:662011. View Article : Google Scholar : PubMed/NCBI

4 

Ferguson C, Alpern E, Miclau T and Helms JA: Does adult fracture repair recapitulate embryonic skeletal formation? Mech Dev. 87:57–66. 1999. View Article : Google Scholar : PubMed/NCBI

5 

Strube P, Sentuerk U, Riha T, Kaspar K, Mueller M, Kasper G, Matziolis G, Duda GN and Perka C: Influence of age and mechanical stability on bone defect healing: Age reverses mechanical effects. Bone. 42:758–764. 2008. View Article : Google Scholar : PubMed/NCBI

6 

Mehta M, Strube P, Peters A, Perka C, Hutmacher D, Fratzl P and Duda GN: Influences of age and mechanical stability on volume, microstructure, and mineralization of the fracture callus during bone healing: Is osteoclast activity the key to age-related impaired healing? Bone. 47:219–228. 2010. View Article : Google Scholar : PubMed/NCBI

7 

Epari DR, Kassi JP, Schell H and Duda GN: Timely fracture-healing requires optimization of axial fixation stability. J Bone Joint Surg. 89:1575–1585. 2007. View Article : Google Scholar : PubMed/NCBI

8 

Ranganathan SI, Ferrari M and Decuzzi P: Design maps for scaffold constructs in bone regeneration. Biomed Microdevices. 15:1005–1013. 2013. View Article : Google Scholar : PubMed/NCBI

9 

Kolar P, Schmidt-Bleek K, Schell H, Gaber T, Toben D, Schmidmaier G, Perka C, Buttgereit F and Duda GN: The early fracture hematoma and its potential role in fracture healing. Tissue Eng Part B Rev. 16:427–434. 2010. View Article : Google Scholar : PubMed/NCBI

10 

Oe K, Miwa M, Sakai Y, Lee SY, Kuroda R and Kurosaka M: An in vitro study demonstrating that haematomas found at the site of human fractures contain progenitor cells with multilineage capacity. J Bone Joint Surg Br. 89:133–138. 2007. View Article : Google Scholar : PubMed/NCBI

11 

Street J, Winter D, Wang JH, Wakai A, McGuinness A and Redmond HP: Is human fracture hematoma inherently angiogenic? Clin Orthop Relat Res. 378:224–237. 2000. View Article : Google Scholar

12 

Beamer B, Hettrich C and Lane J: Vascular endothelial growth factor: An essential component of angiogenesis and fracture healing. HSS J. 6:85–94. 2010. View Article : Google Scholar : PubMed/NCBI

13 

Sarahrudi K, Thomas A, Mousavi M, Kaiser G, Köttstorfer J, Kecht M, Hajdu S and Aharinejad S: Elevated transforming growth factor-beta 1 (TGF-β1) levels in human fracture healing. Injury. 42:833–837. 2011. View Article : Google Scholar : PubMed/NCBI

14 

Ode A, Duda GN, Geissler S, Pauly S, Ode JE, Perka C and Strube P: Interaction of age and mechanical stability on bone defect healing: An early transcriptional analysis of fracture hematoma in rat. PLoS One. 9:e1064622014. View Article : Google Scholar : PubMed/NCBI

15 

Gautier L, Cope L, Bolstad BM and Irizarry RA: Affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics. 20:307–315. 2004. View Article : Google Scholar : PubMed/NCBI

16 

Smyth GK: Limma: Linear models for microarray dataBioinformatics and Computational Biology Solutions using R and Bioconductor. Gentleman R, Carey VJ, Huber W, Irizarry RA and Dudoit S: Springer; New York: pp. 397–420. 2005, View Article : Google Scholar

17 

Wang L, Cao C, Ma Q, Zeng Q, Wang H, Cheng Z, Zhu G, Qi J, Ma H, Nian H and Wang Y: RNA-seq analyses of multiple meristems of soybean: Novel and alternative transcripts, evolutionary and functional implications. BMC Plant Biol. 14:1692014. View Article : Google Scholar : PubMed/NCBI

18 

Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al: Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI

19 

Maere S, Heymans K and Kuiper M: BiNGO: A Cytoscape plugin to assess overrepresentation of Gene Ontology categories in biological networks. Bioinformatics. 21:3448–3449. 2005. View Article : Google Scholar : PubMed/NCBI

20 

Smoot ME, Ono K, Ruscheinski J, Wang PL and Ideker T: Cytoscape 2.8: New features for data integration and network visualization. Bioinformatics. 27:431–432. 2011. View Article : Google Scholar : PubMed/NCBI

21 

Benjamini Y and Hochberg Y: Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Series B. 57:289–300. 1995.

22 

Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C and Jensen LJ: STRING v9. 1: Protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 41:D808–D815. 2013. View Article : Google Scholar : PubMed/NCBI

23 

Klein P, Schell H, Streitparth F, Heller M, Kassi JP, Kandziora F, Bragulla H, Haas NP and Duda GN: The initial phase of fracture healing is specifically sensitive to mechanical conditions. J Orthop Res. 21:662–669. 2003. View Article : Google Scholar : PubMed/NCBI

24 

Mao L, Kawao N, Tamura Y, Okumoto K, Okada K, Yano M, Matsuo O and Kaji H: Plasminogen activator inhibitor-1 is involved in impaired bone repair associated with diabetes in female mice. PLoS One. 9:e926862014. View Article : Google Scholar : PubMed/NCBI

25 

Galliera E, Corsi M and Banfi G: Platelet rich plasma therapy: Inflammatory molecules involved in tissue healing. J Biol Regul Homeost Agents. 26 2 Suppl 1:35S–42S. 2011.

26 

Honczarenko M, Le Y, Swierkowski M, Ghiran I, Glodek AM and Silberstein LE: Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem cells. 24:1030–1041. 2006. View Article : Google Scholar : PubMed/NCBI

27 

Grassi F, Cristino S, Toneguzzi S, Piacentini A, Facchini A and Lisignoli G: CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients. J Cell Physiol. 199:244–251. 2004. View Article : Google Scholar : PubMed/NCBI

28 

Pape HC, Marcucio R, Humphrey C, Colnot C, Knobe M and Harvey EJ: Trauma-induced inflammation and fracture healing. J Orthop Trauma. 24:522–525. 2010. View Article : Google Scholar : PubMed/NCBI

29 

Wang X, Yu YY, Lieu S, Yang F, Lang J, Lu C, Werb Z, Hu D, Miclau T, Marcucio R and Colnot C: MMP9 regulates the cellular response to inflammation after skeletal injury. Bone. 52:111–119. 2013. View Article : Google Scholar : PubMed/NCBI

30 

Tang Y, Wu X, Lei W, Pang L, Wan C, Shi Z, Zhao L, Nagy TR, Peng X, Hu J, et al: TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med. 15:757–765. 2009. View Article : Google Scholar : PubMed/NCBI

31 

Estai MA, Suhaimi F, Das S, Shuid AN, Mohamed Z and Soelaiman IN: Expression of TGF-β1 in the blood during fracture repair in an estrogen-deficient rat model. Clinics (Sao Paulo). 66:2113–2119. 2011. View Article : Google Scholar : PubMed/NCBI

32 

D'Amelio P, Cristofaro MA, Grimaldi A, Ravazzoli M, Pluviano F, Grosso E, Pescarmona GP and Isaia GC: The role of circulating bone cell precursors in fracture healing. Calcif Tissue Int. 86:463–469. 2010. View Article : Google Scholar : PubMed/NCBI

33 

Sandblrg MM, Aro HT and Vuorio EI: Gene expression during bone repair. Clin Orthop Relat Res. 1–312. 1993.PubMed/NCBI

34 

Vo TN, Kasper FK and Mikos AG: Strategies for controlled delivery of growth factors and cells for bone regeneration. Adv Drug Deliv Rev. 64:1292–1309. 2012. View Article : Google Scholar : PubMed/NCBI

35 

Gils A and Declerck PJ: Plasminogen activators inhibitorsPlasminogen: Structure, Activation and Regulation. Waisman DM: Springer; New York: pp. 47–66. 2003

36 

Declerck PJ and Gils A: Three decades of research on plasminogen activator inhibitor-1: A multifaceted serpin. Semin Thromb Hemost. 39:356–364. 2013. View Article : Google Scholar : PubMed/NCBI

37 

Tamura Y, Kawao N, Okada K, Yano M, Okumoto K, Matsuo O and Kaji H: Plasminogen activator inhibitor-1 is involved in streptozotocin-induced bone loss in female mice. Diabetes. 62:3170–3179. 2013. View Article : Google Scholar : PubMed/NCBI

38 

Rundle CH, Wang X, Wergedal JE, Mohan S and Lau KH: Fracture healing in mice deficient in plasminogen activator inhibitor-1. Calcif Tissue Int. 83:276–284. 2008. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Wang C, Qi B, Zhang C and Cheng J: Identification of key genes influenced by fixation stability in early fracture hematoma and elucidation of their roles in fracture healing. Exp Ther Med 14: 4633-4638, 2017.
APA
Wang, C., Qi, B., Zhang, C., & Cheng, J. (2017). Identification of key genes influenced by fixation stability in early fracture hematoma and elucidation of their roles in fracture healing. Experimental and Therapeutic Medicine, 14, 4633-4638. https://doi.org/10.3892/etm.2017.5192
MLA
Wang, C., Qi, B., Zhang, C., Cheng, J."Identification of key genes influenced by fixation stability in early fracture hematoma and elucidation of their roles in fracture healing". Experimental and Therapeutic Medicine 14.5 (2017): 4633-4638.
Chicago
Wang, C., Qi, B., Zhang, C., Cheng, J."Identification of key genes influenced by fixation stability in early fracture hematoma and elucidation of their roles in fracture healing". Experimental and Therapeutic Medicine 14, no. 5 (2017): 4633-4638. https://doi.org/10.3892/etm.2017.5192
Copy and paste a formatted citation
x
Spandidos Publications style
Wang C, Qi B, Zhang C and Cheng J: Identification of key genes influenced by fixation stability in early fracture hematoma and elucidation of their roles in fracture healing. Exp Ther Med 14: 4633-4638, 2017.
APA
Wang, C., Qi, B., Zhang, C., & Cheng, J. (2017). Identification of key genes influenced by fixation stability in early fracture hematoma and elucidation of their roles in fracture healing. Experimental and Therapeutic Medicine, 14, 4633-4638. https://doi.org/10.3892/etm.2017.5192
MLA
Wang, C., Qi, B., Zhang, C., Cheng, J."Identification of key genes influenced by fixation stability in early fracture hematoma and elucidation of their roles in fracture healing". Experimental and Therapeutic Medicine 14.5 (2017): 4633-4638.
Chicago
Wang, C., Qi, B., Zhang, C., Cheng, J."Identification of key genes influenced by fixation stability in early fracture hematoma and elucidation of their roles in fracture healing". Experimental and Therapeutic Medicine 14, no. 5 (2017): 4633-4638. https://doi.org/10.3892/etm.2017.5192
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team